AAAAAA
Results: 26-47/47
Authors:
ZEIS M
UHAREK L
HARTUNG G
GLASS B
DREGER P
Citation: M. Zeis et al., SUPERIOR GRAFT-VERSUS-LEUKEMIA ACTIVITY AFTER TRANSPLANTATION OF PERIPHERAL-BLOOD PROGENITOR-CELL (PBPC) GRAFTS MOBILIZED BY G-CSF AND SCF COMPARED TO G-CSF ALONE, Blood, 90(10), 1997, pp. 2383-2383
Authors:
UHAREK L
ZEIS M
GLASS B
STEINMANN J
DREGER P
GASSMANN W
SCHMITZ N
MULLERRUCHHOLTZ W
Citation: L. Uharek et al., HIGH LYTIC ACTIVITY AGAINST HUMAN LEUKEMIA-CELLS AFTER ACTIVATION OF ALLOGENEIC NK CELLS BY IL-12 AND IL-2, Leukemia, 10(11), 1996, pp. 1758-1764
Authors:
ZEIS M
UHAREK L
GLASS B
DREGER P
STEINMANN J
GASSMANN W
SCHMITZ N
Citation: M. Zeis et al., STRONG GRAFT-VS-LEUKEMIA (GVL) EFFECTS OF IL-2 ACTIVATED NATURAL-KILLER-CELLS GIVEN AFTER BONE-MARROW TRANSPLANTATION, Experimental hematology, 24(9), 1996, pp. 353-353
Authors:
UHAREK L
GLASS B
ZEIS M
DREGER P
GASSMANN W
LOFFLER H
SCHMITZ N
Citation: L. Uharek et al., COMPARISON OF ENGRAFTMENT AND GVL ACTIVITY AFTER ALLOGENEIC BONE-MARROW AND PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION (PBPCT), Experimental hematology, 24(9), 1996, pp. 617-617
Authors:
GLASS B
UHAREK L
ZEIS M
STEINMANN J
DREGER P
GASSMANN W
LOFFLER H
SCHMITZ N
Citation: B. Glass et al., GRAFT-VERSUS-LEUKEMIA ACTIVITY AFTER T-CELL DEPLETION AND CYTOKINE ACTIVATION OF MURINE ALLOGENEIC MHC-IDENTICAL PERIPHERAL-BLOOD PROGENITOR GRAFTS, Experimental hematology, 24(9), 1996, pp. 618-618
Authors:
GLASS B
UHAREK L
ZEIS M
LOEFFLER H
MUELLERRUCHHOLTZ W
GASSMANN W
Citation: B. Glass et al., GRAFT-VERSUS-LEUKEMIA ACTIVITY CAN BE PREDICTED BY NATURAL CYTOTOXICITY AGAINST LEUKEMIA, British Journal of Haematology, 93(2), 1996, pp. 412-420
Authors:
ZEIS M
UHAREK L
GLASS B
STEINMANN J
DREGER P
SCHMITZ N
Citation: M. Zeis et al., SUPERIOR GRAFT-VS-LEUKEMIA EFFECTS AFTER TRANSPLANTATION OF MURINE ALLOGENEIC PERIPHERAL-BLOOD PROGENITOR CELLS (PBPC) AS COMPARED TO BONE-MARROW, Blood, 88(10), 1996, pp. 970-970
Authors:
GLASS B
ZEIS M
UHAREK L
GASKA T
STEINMANN J
GASSMANN W
LOFFLER H
MUELLERRUCHHOLTZ W
Citation: B. Glass et al., HUMAN ALLOGENEIC NK-CELLS ACTIVATED BY IL-2 AND IL-12 EFFICIENTLY LYSE FRESH ACUTE-LEUKEMIA BLASTS, European journal of cancer, 31A, 1995, pp. 36-36
Authors:
ZEIS M
UHAREK L
GLASS B
STEINMANN J
LOFFLER H
MUELLERRUCHHOLTZ W
GASSMANN W
Citation: M. Zeis et al., CELLULAR IMMUNOTHERAPY OF ACUTE-LEUKEMIA WITH NATURAL-KILLER-CELLS INAN ANIMAL-MODEL, European journal of cancer, 31A, 1995, pp. 75-75
Authors:
GLASS B
ZEIS M
UHAREK L
GASSMANN W
STEINMANN J
Citation: B. Glass et al., GENERATION OF ALLOGENEIC T-CELL-LINES FOR LEUKEMIA THERAPY AFTER ALLOGENEIC BMT IN A MURINE MODEL, Experimental hematology, 23(8), 1995, pp. 776-776
Authors:
ZEIS M
GLASS B
UHAREK L
STEINMANN J
SCHMITZ N
GASSMANN W
Citation: M. Zeis et al., ACTIVATION OF ALLOGENIC NK-CELLS BY IL-2 AND IL-12 RESULTS IN HIGH LYTIC ACTIVITY AGAINST FRESH HUMAN LEUKEMIA BLASTS, Experimental hematology, 23(8), 1995, pp. 787-787
Authors:
UHAREK L
GLASS B
ZEIS M
STEINMANN J
SCHMITZ N
GASSMANN W
Citation: L. Uharek et al., IMMUNOTHERAPY USING ALLOGENEIC NK CELLS AFTER BONE-MARROW TRANSPLANTATION IN MICE, Experimental hematology, 23(8), 1995, pp. 808-808
Authors:
ZEIS M
UHAREK L
GLASS B
GASKA T
STEINMANN J
GASSMANN W
LOFFLER H
MULLERRUCHHOLTZ W
Citation: M. Zeis et al., ALLOGENEIC NK CELLS AS POTENT ANTILEUKEMIC EFFECTOR-CELLS AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION IN MICE, Transplantation, 59(12), 1995, pp. 1734-1736
Authors:
ZEIS M
UHAREK L
GLASS B
DREGER P
GASSMANN W
SCHMITZ N
Citation: M. Zeis et al., ALLOGENEIC PERIPHERAL STEM-CELL TRANSPLANTATION IN A MURINE MODEL, Blood, 86(10), 1995, pp. 2279-2279
Authors:
GLASS B
UHAREK L
ZEIS M
STEINMANN J
GASSMANN W
SCHMITZ N
Citation: B. Glass et al., GRAFT-VS-LEUKEMIA (GVL) ACTIVITY-INDUCED BY MHC-MISMATCHED ACTIVATED NATURAL-KILLER-CELLS GIVEN AFTER BONE-MARROW TRANSPLANTATION, Blood, 86(10), 1995, pp. 2292-2292
Authors:
UHAREK L
SEBENS T
ZEIS M
GLASS B
GASSMANN W
SCHMITZ N
STEINMANN J
Citation: L. Uharek et al., LEUKEMIA-SPECIFIC ALLOGENEIC T-CELL-LINES FOR ADOPTIVE IMMUNOTHERAPY THERAPY AFTER ALLOGENEIC BMT IN A MURINE MODEL, Blood, 86(10), 1995, pp. 2293-2293
Authors:
ZEIS M
UHAREK L
GLASS B
GASKA T
GASSMANN W
MUELLERRUCHHOLTZ W
Citation: M. Zeis et al., INDUCTION OF GRAFT-VERSUS-LEUKEMIA (GVL) ACTIVITY IN MURINE LEUKEMIA MODELS AFTER IL-2 PRETREATMENT OF SYNGENEIC AND ALLOGENEIC BONE-MARROWGRAFTS, Bone marrow transplantation, 14(5), 1994, pp. 711-715
Authors:
ZEIS M
UHAREK L
GLASS B
GASKA T
STEINMANN J
GASSMANN W
LOFFLER H
MUELLERRUCHHOLTZ W
Citation: M. Zeis et al., IMMUNOTHERAPEUTIC TRANSFER OF ALLOGENEIC NK CELLS CAN ERADICATE LEUKEMIA AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION IN MICE, Blood, 84(10), 1994, pp. 10000098-10000098
Authors:
UHAREK L
ZEIS M
GLASS B
GASKA T
STEINMANN J
GASSMANN W
LOFFLER H
MUELLERRUCHHOLTZ W
Citation: L. Uharek et al., ALLOGENEIC HUMAN NK CELLS ACTIVATED BY IL-2 AND IL-12 EFFECTIVELY LYSE ACUTE LEUKEMIAS, Blood, 84(10), 1994, pp. 10000501-10000501
Authors:
GLASS B
UHAREK L
ZEIS M
GASKA T
STEINMANN J
GASSMANN W
LOFFLER H
MUELLERRUCHHOLTZ W
Citation: B. Glass et al., CELLULAR IMMUNOTHERAPY OF ACUTE LEUKEMIAS AFTER HIGH-DOSE CHEMOTHERAPY IN A MURINE MODEL, Blood, 84(10), 1994, pp. 10000728-10000728
Authors:
ZEIS M
Citation: M. Zeis, COLOR BECOMES AFFORDABLE, Byte, 18(13), 1993, pp. 125
Authors:
GLASS B
UHAREK L
GASKA T
ZEIS M
GASSMANN W
OEFFLER H
MUELLERRUCHHOLTZ W
Citation: B. Glass et al., CELLULAR IMMUNOTHERAPY USING ALLOGENEIC LYMPHOCYTES FOLLOWING BONE-MARROW TRANSPLANTATION IN A MURINE LEUKEMIA MODEL, Blood, 82(10), 1993, pp. 10000306-10000306